Cargando…

Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?

There are minimal data regarding the management of high risk endometrial cancer histologies lacking invasive disease on the final pathology specimen. This study examines a cohort of these patients and assesses outcomes including time to recurrence and risk of death after management with and without...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Kathryn A., Lopez, Heather, Sun, Lulu, Cripe, James C., Litz, Taylor, Thaker, Premal H., Powell, Matthew A., Mutch, David G., Fuh, Katherine C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541758/ https://www.ncbi.nlm.nih.gov/pubmed/31193699 http://dx.doi.org/10.1016/j.gore.2019.05.007

Ejemplares similares

The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer
por: Carey-Love, Angelina, et al.
Publicado: (2020)

Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care?
por: Cripe, James C., et al.
Publicado: (2019)

Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy?
por: Liang, Brooke, et al.
Publicado: (2019)

Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab
por: Gillen, J., et al.
Publicado: (2019)

How should we monitor patients with acute respiratory failure treated with noninvasive ventilation?
por: Ergan, Begum, et al.
Publicado: (2018)

Obese endometrial cancer survivors’ perceptions of weight loss strategies and characteristics that may influence participation in behavioral interventions
por: Wilson, Elise M., et al.
Publicado: (2021)

Patients with endometrial cancer continue to lack understanding of their risks for cancer
por: Sekhon, Subhjit, et al.
Publicado: (2019)

AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer
por: Divine, Laura M., et al.
Publicado: (2016)

Awareness of the association between obesity and peri-operative risk among newly diagnosed patients with complex atypical hyperplasia and endometrial cancer
por: Kuroki, Lindsay M., et al.
Publicado: (2015)

Surgical radiofrequency ablation of atrial flutter: which operation should we choose?
por: Chen, Fengjie, et al.
Publicado: (2021)

Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer
por: Johns, E.A., et al.
Publicado: (2021)

Persistent inequities in access to and continuity of gynecologic oncology care during the COVID-19 pandemic (052)
por: Bruce, Shaina, et al.
Publicado: (2022)

Should lung biopsies be performed in patients with severe asthma?
por: Doberer, Daniel, et al.
Publicado: (2015)

Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread
por: Sullivan, Stephanie A., et al.
Publicado: (2021)

Anti-IL5/IL5R Treatment in COPD: Should We Target Oral Corticosteroid-Dependent Patients?
por: Laroche, Jérémy, et al.
Publicado: (2023)

Precision medicine in COPD: where are we and where do we need to go?
por: Sidhaye, Venkataramana K., et al.
Publicado: (2018)

Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention
por: Huepenbecker, Sarah P., et al.
Publicado: (2022)

Postablation Endometrial Carcinoma
por: Wortman, Morris, et al.
Publicado: (2017)

A rare case of endometrial cancer metastatic to the uveal choroid
por: Smith, Stephanie H., et al.
Publicado: (2018)

Risk factors and sonographic endometrial thickness as predictors of tumour stage and histological subtype of endometrial cancer
por: Rizzuto, Ivana, et al.
Publicado: (2019)

The final frontier of subdiaphragmatic abscess management: should we bury the scalpel?
por: Menegozzo, Carlos Augusto Metidieri, et al.
Publicado: (2023)

Low grade endometrial stromal sarcoma in pregnancy: A case in support of safe abortion access
por: Furuya, Rachel L., et al.
Publicado: (2023)

Diabetes and periodontal disease: What should we learn next?
por: Naruse, Keiko
Publicado: (2014)

Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
por: Banz-Jansen, Constanze, et al.
Publicado: (2022)

Minimal residual disease in multiple myeloma: are we there yet?
por: Devarakonda, Srinivas, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care
por: Bruce, Shaina F., et al.
Publicado: (2022)

Testing Women With Endometrial Cancer for Lynch Syndrome: Should We Test All?
por: Ma, Jun, et al.
Publicado: (2013)

Observation of CP violation in charm: what should we study next ?
por: Krzemien, Wojciech Jan
Publicado: (2019)

COVID-19 and healthcare systems: What should we do next?
por: Ferrara, P., et al.
Publicado: (2020)

METTL16 in human diseases: What should we do next?
por: Zhang, Hui, et al.
Publicado: (2023)

Glycogen Synthase Kinase 3β Inhibition as a Therapeutic Approach in the Treatment of Endometrial Cancer
por: Yin, Yan, et al.
Publicado: (2013)

Detection of minimal residual disease by next generation sequencing in AL amyloidosis
por: Sarosiek, Shayna, et al.
Publicado: (2021)

Minimally Invasive Glaucoma Surgery: What Do We Know? Where Should We Go?
por: Xin, Chen, et al.
Publicado: (2020)

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery
por: Zamorano, Abigail S., et al.
Publicado: (2022)

Endometrial cancer in an increasingly obese population: Exploring alternative options when surgery may not cut it
por: Staples, Jeanine N., et al.
Publicado: (2018)

Pandemics– One Health preparedness for the next
por: Aarestrup, Frank M., et al.
Publicado: (2021)

Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity
por: McAlarnen, Lindsey A., et al.
Publicado: (2019)

Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins
por: Kulkarni, A., et al.
Publicado: (2023)

PRK Enhancement for Residual Refractive Error After Primary PRK: A Retrospective Study
por: Moshirfar, Majid, et al.
Publicado: (2021)

Prominent decidualization following progestin treatment for endometrial hyperplasia and carcinoma as a mimic of large residual tumor: A cautionary tale
por: Hu, Yang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sr1smflhs7fgehafarekrkpciq